Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
AC0682 / Accutar Biotech
NCT05489679: A Study of AC682 In Chinese Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer	Terminated	1	6	RoW	AC682	Accutar Biotechnology Inc	Breast Cancer	09/23	09/23
NCT05080842: A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer	Terminated	1	21	US	AC682	Accutar Biotechnology Inc	Breast Cancer	04/24	04/24